NUVL
NUVL
US6707031075
Nuvalent, Inc.
Loading chart...

Company Profile

-

Related stocks

PCVX
PCVX • United States
Vaxcyte, Inc.
71.38 USD
10.62B USD 1Y +59.6%
ARWR
ARWR • United States
Arrowhead Pharmaceuticals, Inc.
62.75 USD
8.84B USD 1Y +64.4%
TECH
TECH • United States
Bio-Techne Corp
72.46 USD
11.36B USD 1Y +19.6%
BBIO
BBIO • United States
BridgeBio Pharma, Inc.
65.35 USD
12.78B USD 1Y +17.6%
AXSM
AXSM • United States
Axsome Therapeutics, Inc.
168.35 USD
8.82B USD 1Y +43.3%
HALO
HALO • United States
Halozyme Therapeutics, Inc.
110.42 USD
12.53B USD 1Y +68.5%
PTGX
PTGX • United States
Protagonist Therapeutics, Inc.
143.73 USD
9.3B USD 1Y +114.3%
LGND
LGND • United States
Ligand Pharmaceuticals Incorpor
301.81 USD
6.02B USD 1Y +59.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
United States
Region
North America
Sector
Healthcare
Industry
Biotechnology

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Beta Factor
1.14
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
ende